Total Payments
$2,811
2023 Payments
$296.78
Companies
11
Transactions
278
Medicare Patients
702
Medicare Billing
$103,882
Payment Breakdown by Category
Food & Beverage$2,598 (92.4%)
Education$212.90 (7.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,598 | 270 | 92.4% |
| Education | $212.90 | 8 | 7.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $836.20 | 77 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $621.20 | 57 | $0 (2023) |
| Allergan, Inc. | $394.98 | 37 | $0 (2020) |
| ABBVIE INC. | $236.72 | 33 | $0 (2022) |
| ITI, Inc. | $232.61 | 16 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $221.81 | 42 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $199.73 | 12 | $0 (2022) |
| Indivior Inc. | $26.00 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $17.20 | 1 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $12.46 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $296.78 | 32 | Alkermes, Inc. ($151.31) |
| 2022 | $500.52 | 42 | Alkermes, Inc. ($164.45) |
| 2021 | $794.64 | 76 | Alkermes, Inc. ($230.34) |
| 2020 | $385.82 | 36 | Allergan, Inc. ($188.98) |
| 2019 | $265.96 | 23 | Alkermes, Inc. ($124.17) |
| 2018 | $245.29 | 29 | Sunovion Pharmaceuticals Inc. ($96.73) |
| 2017 | $322.31 | 40 | Sunovion Pharmaceuticals Inc. ($125.08) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: CNS | ||||||
| 11/28/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: Neuroscience | ||||||
| 11/07/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $4.10 | General |
| Category: Neuroscience | ||||||
| 11/02/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: CNS | ||||||
| 10/25/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: Neuroscience | ||||||
| 10/18/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: CNS | ||||||
| 10/03/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: Neuroscience | ||||||
| 09/21/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: CNS | ||||||
| 09/19/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: Neuroscience | ||||||
| 08/22/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: CNS | ||||||
| 08/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: Neuroscience | ||||||
| 08/10/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: CNS | ||||||
| 08/09/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: Neuroscience | ||||||
| 08/01/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: CNS | ||||||
| 07/18/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: Neuroscience | ||||||
| 07/13/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: CNS | ||||||
| 06/28/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: Neuroscience | ||||||
| 06/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: Neuroscience | ||||||
| 05/31/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: Neuroscience | ||||||
| 05/18/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Neuroscience | ||||||
| 05/12/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: CNS | ||||||
| 04/26/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Neuroscience | ||||||
| 04/06/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: CNS | ||||||
| 03/23/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Education | In-kind items and services | $62.99 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 157 | 430 | $100,985 | $25,810 |
| 2022 | 5 | 169 | 565 | $100,248 | $30,927 |
| 2021 | 5 | 160 | 547 | $98,320 | $19,941 |
| 2020 | 4 | 216 | 690 | $128,936 | $27,203 |
Total Patients
702
Total Services
2,232
Medicare Billing
$103,882
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 187 | $37,400 | $10,369 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 161 | $32,200 | $7,898 | 24.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 29 | 35 | $10,360 | $2,859 | 27.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 16 | $8,912 | $1,886 | 21.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 11 | 12 | $6,888 | $1,427 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 19 | $5,225 | $1,372 | 26.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 301 | $49,217 | $15,634 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 198 | $34,650 | $11,247 | 32.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 19 | $7,880 | $2,460 | 31.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 16 | 16 | $3,696 | $1,241 | 33.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 31 | $4,805 | $344.30 | 7.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 27 | 254 | $42,560 | $7,341 | 17.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 71 | 207 | $32,085 | $6,537 | 20.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 26 | $10,400 | $2,554 | 24.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 26 | 37 | $9,250 | $2,000 | 21.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 23 | $4,025 | $1,510 | 37.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 63 | 402 | $67,110 | $11,970 | 17.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 203 | $35,525 | $8,952 | 25.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 34 | 35 | $13,894 | $3,541 | 25.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 49 | 50 | $12,407 | $2,740 | 22.1% |
About Dr. Mark Diercks, M.D
Dr. Mark Diercks, M.D is a Psychiatry healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134283567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Diercks, M.D has received a total of $2,811 in payments from pharmaceutical and medical device companies, with $296.78 received in 2023. These payments were reported across 278 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,598).
As a Medicare-enrolled provider, Diercks has provided services to 702 Medicare beneficiaries, totaling 2,232 services with total Medicare billing of $103,882. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Omaha, NE
- Active Since 12/20/2006
- Last Updated 03/21/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134283567
Products in Payments
- ARISTADA (Drug) $799.49
- VRAYLAR (Drug) $618.36
- INVEGA SUSTENNA (Drug) $550.59
- CAPLYTA (Drug) $232.61
- LATUDA (Drug) $221.81
- ABILIFY MAINTENA (Drug) $166.61
- INVEGA TRINZA (Drug) $70.61
- Aristada 441 mg (Drug) $36.71
- REXULTI (Drug) $33.12
- PERSERIS (Drug) $26.00
- AUSTEDO (Drug) $17.20
- NUEDEXTA (Drug) $12.46
- LINZESS (Drug) $12.41
- NAMZARIC (Drug) $8.77
- VIIBRYD (Drug) $4.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Omaha
Vithyalakshmi Selvaraj, M.b.b.s, M.B.B.S
Psychiatry — Payments: $1.2M
Psychiatry $1.2M
Dr. Sarit Hovav, M.d, M.D
Psychiatry — Payments: $467,341
Psychiatry $467,341
Mary Jo Hanigan, Md, MD
Psychiatry — Payments: $123,744
Psychiatry $123,744
Dr. Michael Sedlacek, Md, MD
Psychiatry — Payments: $21,436
Psychiatry $21,436
Syed Sattar, M.d, M.D
Psychiatry — Payments: $17,220
Psychiatry $17,220
Dr. Elizabeth Fitzpatrick, M.d, M.D
Psychiatry — Payments: $11,881
Psychiatry $11,881